NCT02452229

Brief Summary

Herpes simplex virus, cytomegalovirus and varicella zoster virus infection are purported to play a pivotal role in morbidity and mortality in burns. Thus far, there is no existing systematic review (Level of Evidence III or higher) describing the unique role as well as concurrent infections of these viruses in burns. The aim of this review is to point out the clinical differences between these human herpes virus subtypes, to outline established therapy approaches, and to provide evidence for virus related morbidity and mortality in burns.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,267

participants targeted

Target at P75+ for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

May 14, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 22, 2015

Completed
Last Updated

May 22, 2015

Status Verified

May 1, 2015

Enrollment Period

2 months

First QC Date

May 14, 2015

Last Update Submit

May 19, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Human Herpes Virus (HHV) Infections

    HHV include the herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), varicella zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr viruses (EBV) and human herpes virus 6 to 8

    Participants will be followed for the duration of hospital stay, an expected average of 3 months.

Secondary Outcomes (1)

  • Treatment of Human Herpes Virus (HHV) Infections

    Participants will be followed for the duration of hospital stay, an expected average of 3 months.

Study Arms (1)

Burn patients

The included patient are burn victims who sustained a burn of at least 1 % total body surface are (TBSA); with no restriction on age.

Other: Review of the Literature for Human Herpes Virus infections

Interventions

Review of the Medline database (PubMed and Ovid interface) for human herpes virus infections in burns as well as Web of Science interface. PRIMSA (preferred reporting items for systematic reviews and meta-analyses) guidelines and checklist were used.

Burn patients

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Every year, about 500,000 citizens of the United States of America were burned; 50,000 of them were admitted to Burn Center. Bacterial and viral infections including cellulitis, pneumonia, wound infections and septicemia are among the top ten complications of burn injuries. Severe burn injury causes an increased inflammatory response and an overall immunosuppression. As a result severely burned patients are more prone to infections and septicemia. Early treatment of sepsis and prevention of infections are key to reducing morbidity and improving the long-term outcome of burn victims.

You may qualify if:

  • Patients who presented with at least 1% TBSA burned
  • Patients who presented with a viral infections during their hospitalization

You may not qualify if:

  • Patients who had no burns
  • Patients who had no viral infections during their hospitalization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336-41. doi: 10.1016/j.ijsu.2010.02.007. Epub 2010 Feb 18. No abstract available.

    PMID: 20171303BACKGROUND

MeSH Terms

Conditions

Herpes SimplexChickenpoxBurns

Condition Hierarchy (Ancestors)

Herpesviridae InfectionsDNA Virus InfectionsVirus DiseasesInfectionsSkin Diseases, ViralSkin Diseases, InfectiousSkin DiseasesSkin and Connective Tissue DiseasesVaricella Zoster Virus InfectionWounds and Injuries

Study Officials

  • David N Herndon, MD, FACS

    Department of Surgery, University of Texas Medical Branch and Shriners Hospitals for Children, Galveston, Texas, USA

    STUDY CHAIR

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 14, 2015

First Posted

May 22, 2015

Study Start

March 1, 2015

Primary Completion

May 1, 2015

Last Updated

May 22, 2015

Record last verified: 2015-05